The ADP-glucose pyrophosphorylase from Escherichia coli comprises two tightly bound distinct domains  by Bejar, Clarisa M. et al.
FEBS 28713 FEBS Letters 573 (2004) 99–104The ADP-glucose pyrophosphorylase from Escherichia coli comprises
two tightly bound distinct domainsClarisa M. Bejara, Miguel A. Ballicoraa, Diego F. Gomez-Casatib,
Alberto A. Iglesiasc, Jack Preissa,*
aDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824, USA
bInstituto Tecnologico Chascomus (INTECH), Pcia. de Buenos Aires, Argentina
cGrupo de Enzimologıa Molecular, Cat. Bioq. Basica Macromol., Fac. Bioquimica y Cs. Biologicas, U.N.L., Santa Fe, Argentina
Received 24 June 2004; revised 19 July 2004; accepted 20 July 2004
Available online 3 August 2004
Edited by Stuart FergusonAbstract Computational analysis of ADP-glucose pyrophos-
phorylases predicts a fold with two domains. Co-expression of
two polypeptides comprising residues 1–323 and 328–431 from
the Escherichia coli ADP-glucose pyrophosphorylase yielded an
enzyme form as active as the wild type. The only diﬀerence from
the wild type was a slightly modiﬁed aﬃnity for allosteric
eﬀectors. The two polypeptides could not be separated by
chromatographic procedures. Separate expression of these
polypeptides produced inactive unstable forms. All these results
indicated that the ADP-glucose pyrophosphorylase comprises
two domains with a strong interaction between them. That
interaction is important for allosteric properties and structural
stability.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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ADP-glucose pyrophosphorylase (ADP-Glc PPase1, EC
2.7.7.27) catalyzes the formation of ADP-glucose (ADP-Glc)
and release of PPi from glucose 1-phosphate (Glc1P) and ATP.
This is the ﬁrst committed step in the synthesis of bacterial
glycogen and starch in plants [1,2]. The ADP-Glc PPase is the
key regulatory enzyme of the pathway and its activity is al-
losterically controlled by intermediates of the major carbon
assimilatory pathway of the organism. For example, fructose
1,6-bisphosphate (FBP) activates the enzyme from Escherichia
coli, whereas AMP is an inhibitor [1]. Other secondary acti-
vators of the E. coli enzyme are phosphoenolpyruvate (PEP),
pyridoxal 50-phosphate (PLP), and reduced nicotinamide ad-
enine dinucleotides [3]. The reaction is reversible and can be* Corresponding author. Fax: +517-353-9334.
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phosphorolysis of ADP-Glc (reverse). In vivo, the reaction
proceeds mainly in the synthesis direction [4].
The ADP-Glc PPases from enterobacteria are homotetra-
mers (a4) composed by subunits of 50 kDa (440 residues)
encoded by the glgC gene [1]. The three dimensional structure
of these enzymes is not available, but structural and compu-
tational analyses predict that the fold of ADP-Glc PPases has
two domains [1,5]. Despite the low homology (20% identity),
the predicted structure of the central part of the ADP-Glc
PPases (residues 20–300) resembles other nucleotide-
diphosphate-sugar pyrophosphorylases (NDP-sugarPPase) and
it is postulated to be the catalytic core of the enzyme [1,5]. On
the other hand, the C-terminus (100 residues) was proposed
to be important for regulation and speciﬁcity for activators [6].
A similar conclusion has been reached for plant ADP-Glc
PPases [2]. Both domains are postulated to interact to regulate
the activity because there are residues near the N-terminus that
participate in the regulatory site [7–10]. In addition, the pres-
ence of an N-terminal tail (10–20 residues) strongly deter-
mines the allosteric properties of the enzyme [11,12].
Partial proteolysis has been a classical procedure to probe
domain boundaries [13–15]. In this paper, we used molecular
biology techniques to test the 2-domain hypothesis. We di-
vided the enzyme into two polypeptides corresponding to the
putative domains, co-expressed them, puriﬁed the forms ob-
tained, and characterized their properties.2. Materials and methods
2.1. Materials
Synthesis and puriﬁcation of oligonucleotides, and DNA sequencing
were performed by the Genomics Technology Support Facility at
Michigan State University. Perfect ProteinTM marker was obtained
form Novagen, Inc. The Mono-Q HR 10/10, 5/5 and Phenyl-Superose
columns were purchased from Amersham Pharmacia Biotech. [32P]PPi
was purchased from Perkin–Elmer Life Sciences and [14C]Glc1P from
Amersham Pharmacia Biotech. All other reagents were purchased at
the highest quality available.
2.2. Plasmids and expression vectors
The construction of pETEC, a pET24a derivative with the E. coli
ADP-Glc PPase, has been previously described [6]. Plasmids pMAB5
and pMAB6 are modiﬁed versions of the respective compatible ex-
pression vectors pMON17335 and pMON17336 [16]. They have an
NdeI rather than NcoI site for cloning.blished by Elsevier B.V. All rights reserved.
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Random introduction of a single 15-bp insertion per plasmid (pE-
TEC) was performed by the technique of Hallet et al. [17] with the
commercial GPSTM linker-scanning mutagenesis kit from New En-
gland Biolabs. From 130 insertions mutants obtained, 20 colonies had
a single 15 bp inserted in the ADP-Glc PPase coding region. The
plasmid with the insertion mutant 117 (pETEC-ins117) was selected
for further studies and subcloned in pMAB5 (pMAB5-Ec-ins117) after
digestion with NdeI–SacI for expression in AC70R1-504 cells.
2.4. Truncated protein constructs
To obtain an enzyme with a C-terminal truncation of 108 residues
(Ec1–323), DNA from the 3
0 coding region of the E. coli ADP-Glc PPase
gene was removed as follows. A PCR fragment was ampliﬁed using
pETEC-ins117 as a template, T7 promoter primer (50-TA-
ATACGACTCACTATAGGG-30) and the oligonucleotide 50-AC-
CGGAGAGCTCTGTTTAAACACG-30, which introduced a SacI site
3 bp after the previously inserted stop codon. The PCR fragment was
subcloned into an NdeI–SacI digested pMAB5 to obtain pMAB5-
Ec1–323.
2.5. Construction of a plasmid for expression of the C-terminus alone
(Ec328–431)
The DNA fragment encoding the C-terminal portion (Ec328–431)
was ampliﬁed from pETEC with the T7 terminator primer (50-
GCTAGTTATTGCTCAGCGG-30) and the oligonucleotide 50-GGT-
AGCCACCATATGACCCTTAACT-30, which introduced an NdeI
site. The fragment was subcloned into pMAB6 using the sites NdeI and
SacI to obtain pMAB6-Ec328–431. The coding regions of all ﬁnal
products were veriﬁed by DNA sequencing. Fig. 1 summarizes the
ADP-Glc PPase constructs used in this work.
2.6. Bacterial strains and expression of the recombinant enzymes
Escherichia coli AC70R1-504 cells without endogenous ADP-Glc
PPase activity were used for expression of the enzymes subcloned in
pMAB5 and pMAB6 [16]. The expression of pMAB5-Ec-ins117 and
pMAB5-Ec1–323 was performed as described previously for pML10
[18]. Expression of pMAB6-Ec328–431 was performed as described
previously for pMON17336 [16]. Co-expression of pMAB5-Ec1–323 and
pMAB6-Ec328–431 was performed as was described previously for
plasmids pML10 and pMON17336 [18].
2.7. Protein methods
Protein assay, electrophoresis (SDS–PAGE) and immunoblotting
were performed as described previously [5]. N-terminal peptide
sequence determination of blotted samples onto PVDF membranes
(Bio-Rad) and soluble pure protein samples were performed at the
Macromolecular Structure, Sequencing and Synthesis Facility at
Michigan State University. Desalting was performed on Bio-Rad 10
DG chromatography columns. Samples were concentrated with
Centricon-30 devices (Amicon Inc.).
2.8. Enzymatic assays
Assay A: Pyrophosphorolysis direction. Formation of [32P]ATP from
[32P]PPi was determined by the method of Morell et al. [19]. The re-
action was carried out for 10 min at 37 C in a mixture that contained
50 mM HEPES (pH 8.0), 7 mM MgCl2, 1.5 mM [
32P]PPi (1500–2500
cpm/nmol), 2 mM ADP-Glc, 4 mM NaF, and 0.05 mg/ml bovine se-Fig. 1. E. coli ADP-Glcrum albumin, plus enzyme in a total volume of 0.250 ml. Unless other
activators were assayed or speciﬁcally stated, 2 mM FBP was added in
the reaction mixture.
Assay B: Synthesis direction. Formation of ADP-[14C]Glc from
[14C]Glc-1P was determined by the method of Yep et al. [20]. The
reaction was carried out for 10 min at 37 C in a mixture that con-
tained 50 mM HEPES (pH 8.0), 7 mM MgCl2, 0.5 mM [
14C]Glc-1P
(1000 dpm/nmol), 1.5 mM ATP, 1.5 units/ml pyrophosphatase, and
0.2 mg/ml bovine serum albumin, plus enzyme in a total volume of 0.20
ml, unless speciﬁcally stated. Unless other activators were tested, 2 mM
FBP was added in the reaction mixture. One unit of enzymatic activity
is one lmol of product, either [32P]ATP or ADP-[14C]Glc, formed per
min at 37 C.
2.9. Puriﬁcation of Ec-ins117
After induction, 20 liters of AC70R1-504 cells transformed with
pMAB5-Ec-ins117 was harvested and crude extracts were obtained as
described previously [18]. The crude extract was precipitated with a 30–
60% ammonium sulfate cut. After centrifugation, the precipitate was
redissolved in buﬀer A (50 mMHEPES, pH 8.0, 5 mMMgCl2, 0.1 mM
EDTA and 10% sucrose) and desalted. The sample was applied onto a
DEAE-Fractogel column (EMD Chemicals) and eluted with a linear
NaCl gradient (0–0.5 M). The active fractions were pooled, desalted,
applied to a Green A (Amicon Corp., Lexington, MA) aﬃnity chro-
matography column (1 ml bed volume) and eluted with a 20 ml linear
gradient of NaCl (0–2 M). Purest fractions were pooled, desalted,
concentrated, and applied onto a Mono Q HR 5/5 (FPLC, Pharmacia)
column equilibrated with buﬀer A and eluted with a linear NaCl gra-
dient (0–0.5 M). The post-Mono Q fractions were pooled, concen-
trated, resuspended in buﬀer B (buﬀer A plus 1.2 M ammonium
sulfate), and applied on a Phenyl-Superose (FPLC, Pharmacia) col-
umn equilibrated with buﬀer B. The sample was eluted with a de-
creasing linear gradient of ammonium sulfate (1.2–0.001 M). The
purest fractions were pooled, concentrated, and applied to a Phar-
macia Superdex 200 HR 10/30 column equilibrated with buﬀer A. The
gel ﬁltration chromatography was run at a ﬂow rate of 0.25 ml/min and
fractions with activity were pooled. After this step, Ec-ins117 was
>95% pure, with a speciﬁc activity of 180 U/mg in the pyrophos-
phorolysis direction assay (Table 1).
2.10. Puriﬁcation of Ec1–323
The protein was monitored by immunoblot throughout the puriﬁ-
cation steps. AC70R1-504 cells harboring pMAB5-Ec1–323 were grown
and induced in 4 liters of LB medium. Crude extracts were precipitated
with 0–30% ammonium sulfate and the pellet was resuspended in buﬀer
A and desalted. Samples were further puriﬁed with a Mono Q HR 10/
10 and a Green A aﬃnity column as indicated above (Table 1). The
fractions containing the enzyme, 50–60% pure as detected by im-
munoblot analysis, were pooled, concentrated, and stored at )80 C.
2.11. Puriﬁcation of co-expressed Ec1–323 +Ec328–431
AC70R1-504 cells co-transformed with pMAB5-Ec1–323 + pMAB6-
Ec328–431 were grown and induced in a 1-liter culture. The resulting
crude extracts were applied onto a DEAE-Fractogel column (EMD
Chemicals Inc.) and eluted with a linear NaCl gradient (0–0.5 M). The
active fractions were pooled and precipitated with 30–60% ammonium
sulfate. After centrifugation, the pellet was resuspended in buﬀer A and
desalted. The sample was applied to a Mono Q HR 10/10 (FPLC,PPase constructs.
Table 1
Speciﬁc activities of mutant and wild-type E. coli ADP-Glc PPases
Sample Speciﬁc activity Puritya (%)
Pyrophosphorolysis
(U/mg)
Synthesis
(U/mg)
Wild-type 131 3 54 1 90
Ec-ins117 180 9b NDc >95
Ec1–323 < 0.001 <0.0001 50–60
Ec1–323 +Ec328–341 132 5 43 1 >95
Concentration of FBP for the mutants was raised to 4 mM. For the
sample Ec1–323 +Ec328–341, concentration of ATP (synthesis direction)
was raised to 5 mM.
a Purity of the samples was estimated from SDS–PAGE gels.
bAnother independent puriﬁcation produced a pure sample with an
activity of 140 U/mg.
cNot determined.
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NaCl gradient (0–0.5 M). Purest fractions, assessed by SDS–PAGE,
were pooled, concentrated and applied to a Green A aﬃnity chro-
matography column. The sample was eluted with a linear gradient of
NaCl (0–2 M). After this step both co-expression products,
Ec1–323 +Ec328–431 accounted for >95% of the protein (Table 1).
2.12. Molecular mass determination
Puriﬁed wild-type E. coli ADP-Glc PPase and the mutants Ec-
ins117, Ec1–323 +Ec328–431, and Ec1–323 were applied to a column
Pharmacia Superdex 200 HR 10/30 equilibrated with buﬀer A and run
at 0.25 ml/min. Peaks were followed by absorbance at 280 nm, tested
for enzymatic activity or conﬁrmed by immunoblot (Ec1–323). For
calibration, ferritin (440 kDa), E. coli ADP-Glc PPase (200 kDa), al-
dolase (158 kDa), and hemoglobin (67 kDa) were used as standard
proteins. The calibration line and the interval conﬁdence (90%) were
obtained after plotting the data as log (molecular mass) vs. elution
volume in the program Origin 5.0. Molecular mass was expressed
with a conﬁdence interval of 90%.
2.13. Kinetic characterization
Kinetic data were plotted as speciﬁc activity (lmolmin1 mg1) vs.
substrate or eﬀector concentration. Kinetic constants were acquired by
ﬁtting the data to the Hill equation with a non-linear least square
formula using the program OriginTM 5.0. Hill plots were used to cal-
culate the Hill coeﬃcient nH and the kinetic constants that correspond
to the activator, substrate or inhibitor concentrations giving 50% of the
maximal activation (A0:5), velocity (S0:5), and inhibition (I0:5).Fig. 2. SDS–PAGE of E. coli wild-type ADP-Glc PPase and Ec-ins117
mutant. Lane 1, E. coli wild-type ADP-Glc PPase; lane 2, pre-stained
molecular mass markers; lane 3, Ec-ins117 mutant (0.5 lg); and lane 4,
Ec-ins117 mutant (1.5 lg).3. Results and discussion
Random insertions of a single 15-bp fragment into a re-
combinant E. coli glg C gene were produced to study struc-
ture–function relationships on the ADP-Glc PPase
(unpublished results). One of the insertion mutants generated,
Ec-ins117, had a stop codon after residue 323 in the translated
polypeptide of the E. coli glgC gene. Surprisingly, the poly-
peptide still possessed ADP-Glc PPase activity although the
stop codon would truncate 108 residues of the C-terminus.
Colonies of BL21(DE3) cells expressing Ec-ins117 or the wild-
type enzyme, but not a control plasmid (pET24a), stained
brown in the presence of iodine vapors (unpublished results).
This indicated high levels of glycogen in the cell and suggested
the presence of ADP-Glc PPase activity [21]. For this reason,
we characterized the properties of this putatively truncated
form.
3.1. Puriﬁcation and characterization of Ec-ins117
Despite the lower expression level of Ec-ins117 as observed
by immunoblot and SDS–PAGE (not shown), the pyrophos-phorolysis activity of this mutant was 0.31 U/mg in the crude
extracts. That was two orders of magnitude lower than the
overexpression of the wild-type ADP-Glc PPase but two or-
ders of magnitude higher than pET24a, the plasmid control
without insert (not shown). Attempts to isolate this 37 kDa
truncated protein resulted in the co-puriﬁcation of a 12-kDa
peptide even after ﬁve diﬀerent chromatographic columns
(Fig. 2). Despite the diﬀerences in molecular size, both poly-
peptides comigrated in a high-resolution gel ﬁltration column
(Superdex 200 HR). The N-terminal sequence of the 12-kDa
band, obtained after SDS–PAGE and blotting, was
MTLNSLVSGG, which indicated that the polypeptide corre-
sponds to the C-terminus of the E. coli ADP-Glc PPase with
residue 328 as the N-terminal methionine (103 amino acids). In
addition, N-terminal sequencing of the puriﬁed Ec-ins117 in
solution conﬁrmed the presence of two polypeptides. There
were both the C-terminal fragment together with the N-ter-
minus of the enzyme (37 kDa band). It also indicated that the
stoichiometry of the 37 and 12 kDa polypeptides was 1:1
(Fig. 3). Based on the sequence data, the polypeptide of 12
kDa appeared to be the product of an open reading frame that
starts 24 bp downstream of the inserted stop codon, at Met328
(Fig. 4). The lower expression of this hetero-oligomer form can
be explained by the absence of a proper ribosome-binding site
before Met328. Kinetic properties of the Ec-ins117 mutant
purest sample were determined in the pyrophosphorolysis di-
rection (Table 2). Apparent aﬃnities for the substrates (ADP-
Glc, PPi), and cofactor (Mg
2þ), were similar to those of the
wild-type enzyme. The main diﬀerence was the apparent af-
ﬁnity for the activators. The A0:5 for FBP was almost 6-fold
higher for Ec-ins117 compared to the wild type.
Fig. 3. N-terminal sequence analysis of the Ec-ins117 mutant Automated sequencing of the Ec-ins117 protein was performed directly from the purest
fraction. The values are the picomoles of amino acid derivative found in each cycle of degradation. In each cycle of cleavage, major peaks are in bold.
Residues Q, G, H, A, R, Y, P, W, F, I were negligible in all these cycles and were omitted for simplicity. ND: Not detectable.
Fig. 4. Sequence of the insertion 117 in the E. coli ADP-Glc PPase. The upper sequence corresponds to the wild-type ADP-Glc PPase and the lower
to the Ec-ins117, in which a 15-bp linker was inserted by linker-scanning mutagenesis as described in section 2. Underlined is the 15-bp insertion. A
stop codon was introduced at residue 324, generating the transcription and translation of two polypeptides: the 37 kDa (comprising residues 1-323),
and the 12 kDa peptide starting at Met328.
Table 2
Apparent aﬃnity for the diﬀerent eﬀectors of the mutant Ec-ins117
and wild-type ADP-Glc PPase
Eﬀectors Enzyme
Wild type Ec-ins117 Ratioa
Substrates S0:5 (lM)
ADP-Glc 166 26 241 25 1.45
PPi 81 14 45 13 0.55
Cofactor S0:5 (lM)
Mg2þ 1420 310 2147 86 1.51
Activators A0:5 (lM)
FBP 37.8 5.2 214 53 5.7
PLP 0.045 0.004 0.156 0.001 3.5
PEP 282 15 >2000b >7.1
Inhibitor I0:5 (lM)
AMP 41 4c 21 8d 0.51
The assays were performed in the pyrophosphorolysis direction.
a This is the value of the kinetic constant of Ec-ins117 divided the wild
type.
b Saturation was not reached.
c To observe AMP inhibition, activator should be added. In this case,
FBP was 40 lM to avoid saturating concentrations of activator and
allowed the competitive inhibition by AMP. That concentration is
about the A0:5 value.
d FBP was 300 lM, which is about the A0:5 value.
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forms
It was important to determine whether the truncated enzyme
was active by itself or if the co-expression with the C-terminal
12 kDa polypeptide contributed to the reconstitution of the
activity. To ensure the expression of a single polypeptide
comprising residues 1–323 (Ec1–323), a SacI restriction site was
introduced immediately downstream of the stop codon by site-
directed mutagenesis. Only the Ec1–323 coding fragment was
subcloned in pMAB5, expressed, and puriﬁed as described
under Section 2. With this approach, most of the expressed
enzyme was insoluble, whereas the soluble fraction had a
peptide of about 37 kDa and some lower bands recognized by
immunoblotting, which indicated that it was highly proteo-
lyzed (data not shown). Ec1–323 (37 kDa) was puriﬁed to
50% purity where the main contaminants were lower bands
still recognized by immunoblot. The activity was negligible
(Table 1) and did not increase signiﬁcantly with higher con-
centrations of FBP, up to 10 mM (data not shown). Gel ﬁl-
tration showed that the sample was highly aggregated (data
not shown).
The total loss of activity after the removal of the C-terminus
indicated that this domain is involved in more than regulation.
In the inactive Ec1–323 mutant, the C-terminal deletion yielded
Table 3
Kinetic parameters in the synthesis direction of E. coli ADP-Glc PPase wild type and Ec1–323 +Ec328–431 form
Enzyme ATP Glc1P FBP AMP
S0:5 (lM) nH S0:5 (lM) nH A0:5 (lM) nH I0:5a (lM) nH I0:5b (lM) nH
Wild type 301 14 1.9 15.0 1.3 1.0 92 1 2.1 3.8 0.4 1.1 92 4 2.7
Ec1–323 +Ec328–431 1410 51 2.9 13.6 1.2 1.2 327 15 2.0 10 2 1.2 41 3 0.9
Except for the ATP curves, the concentration of ATP for the Ec1–323 +Ec328–431 was 5 mM to ensure saturation. For the ATP and Glc1P curves, the
concentration of FBP was 2 mM for the wild type and 4 mM for Ec1–323 +Ec328–431.
a Inhibition curve performed in the presence of 30 lM FBP.
b Inhibition curve performed in the presence of 130 lM FBP.
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which speciﬁc regions of this domain were important, deletions
of 20–90 residues (every 10) from the C-terminus were evalu-
ated. The truncated enzymes were expressed in small-scale
systems and were visualized by SDS–PAGE and Western blot
at their expected molecular sizes (data not shown). The re-
combinant products were found mainly in the insoluble frac-
tion of the sample and the pyrophosphorolysis ADP-Glc
PPase activity was negligible in all crude extracts (<0.0001 U/
mg). These results suggest that most of, or maybe all of the
100 residues of the C-terminus are necessary for maintaining
a functional E. coli ADP-Glc PPase. It may be due to the role
of speciﬁc residues or due to the overall structure of the do-
main that is necessary for the integrity of the enzyme.
3.3. Characterization of Ec1–323 +Ec328–431
The results obtained with Ec1–323 strongly suggested that the
properties of Ec-ins117 are due to the presence of both the 37-
and the 12-kDa polypeptides. To verify this possibility, the E.
coli glgC fragment encoding the 103 C-terminal residues of
ADP-Glc PPase (Ec328–431) was subcloned into a compatible
expression vector (pMAB6). Co-expression of Ec1–323 and
Ec328–431 was performed in AC70R1-504 cells, yielding extracts
with activity (39 U/mg) comparable to the wild type (24 U/mg)
[6]. That level of expression was about 100-fold higher than the
Ec-ins117. After the same puriﬁcation procedure of the wild-
type enzyme, Ec1–323 and Ec328–431 co-puriﬁed, indicating aFig. 5. Domain organization of the ADP-Glc PPase from E. coli The seconda
represent b-sheets and a-helices, respectively. Dark circles are important resid
and Pro295 are replaced, allosteric mutants are generated [1]. After insertion o
Fig. 4).very strong interaction. The 37-kDa fragment did not appear
as proteolyzed as when it was expressed alone (data not
shown). In addition, the speciﬁc activity values were compa-
rable to that of the wild-type enzyme (Table 1). The molecular
mass determined by gel ﬁltration in native conditions of the co-
expressed Ec1–323 +Ec328–431 (227 32 kDa) and Ec-ins117
mutant (213 30 kDa) was not distinguishable from the wild-
type enzyme (200 kDa). These results, together with the 1:1
stoichiometry (Fig. 3), indicate that the structures of both
Ec1–323 +Ec328–431 and Ec-ins117 are a04x4, rather than a4 as
the wild type (a0 and x being the polypeptides Ec1–323 and
Ec328–431, respectively). The apparent aﬃnity for the substrate
ATP (4.7-fold higher S0:5) and for the activator FBP (3.5-fold
higher A0:5 in the synthesis direction) was altered compared to
those of the wild type (Table 3). The inhibition by AMP was
not signiﬁcantly changed and the apparent aﬃnity for Glc1P
was identical (Table 3).4. Conclusions
Important structural information can be inferred from these
results: (i) the stop codon inserted in the Ec-ins117 mutant,
which generated a ‘‘nick’’ in the protein sequence, was in a
non-critical position for the 3D structure of the protein.
(ii) These data also support structure predictions and the hy-
pothesis that the E. coli ADP-Glc PPase is organized in at leastry structure is based on the prediction from [1,2]. Arrows and cylinders
ues that interact with eﬀectors or participate in catalysis. When Gly336
f a stop codon, residues between Ser323 and Met328 were ‘‘nicked’’ (see
104 C.M. Bejar et al. / FEBS Letters 573 (2004) 99–104two distinct domains [1]. According to the proposed model of
domain organization [1,2,5], the stop codon was inserted in a
loop that separates the two putative domains (Fig. 5). The data
also agree with the hypothesis that the C-terminal domain is
100 residues long and linked to the catalytic domain by a
long loop (30 residues) [1]. Removal of this domain yielded
an inactive enzyme rather than a shorter unregulated version
as other NDP-sugar PPases of 30–40 kDa [22–25]. Even the
removal of 20 residues at the C-terminus rendered a form
without activity. It is possible that the absence of even a small
part of the C-terminal domain leaves the enzyme in a mis-
folded or insoluble form. On the other hand, a ‘‘nick’’ sepa-
rating the C-terminus and the catalytic domain, obtained by
the co-expression of both the N- and the C-terminal poly-
peptides, produced an enzyme with very similar properties to
the wild type. Only the apparent aﬃnity for the activator was
slightly modiﬁed. Possibly, the lack of a covalent bond be-
tween the N- and C-domains yields a more relaxed enzyme
that favors less the activated conformation. A slightly higher
concentration of activator overcame this problem, 3.5- and
5.7-fold in the synthesis and pyrophosphorolysis direction,
respectively. We cannot rule out the possibility that the resi-
dues removed in the ‘‘nick’’ (S323GSHG327) are the reason for
the decrease in activator aﬃnity. However, in other ADP-Glc
PPases, those residues are not conserved or they are deleted,
together with Met328 [1]. Most likely, they are part of an area
that connects the two major domains and does not play a
speciﬁc role (Fig. 5).
Partial proteolysis has been a classical procedure to detect
domain boundaries [13–15]. In this paper, we used molecular
biology techniques to probe whether the E. coli ADP-Glc
PPase comprises two domains. After co-expression of the C-
and the N-terminal domains, they remained non-covalently
bound, with a tight interaction that cannot be disturbed even
after passage through several chromatography columns.
Presence of the C-terminal domain stabilizes the enzyme and
prevents proteolytic degradation of the N-terminal domain.
These results provide a structural insight for the diﬀerential
roles of these regions of the ADP-Glc PPase. We propose that
they are two strongly interacting domains that have to be ex-
pressed together to obtain a fully functional enzyme. Ac-
cording to previous analysis [1,5], the catalytic domain is
located in the 37 kDa fragment (similar to most NDP-sugar
PPases) and the responsibility for the regulation is shared by
both the 12 and the 37 kDa fragments.
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